fbpx
Medical Innovation Exchange

Amgen's heart drug reduces cardiovascular disease risk factor in phase 2 trial

https://www.fiercebiotech.com/biotech/amgens-heart-drug-reduces-cardiovascular-disease-risk-factor-phase-2-trial

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.